View Article

Abstract

Natural products (NPs) derived from plants, microorganisms, marine organisms, and animals have played a fundamental role in the discovery and development of therapeutic agents. Their exceptional structural diversity, stereochemical complexity, and ability to interact with biologically relevant targets make them valuable sources of drug leads. Historically important medicines such as morphine, quinine, paclitaxel, artemisinin, and penicillin demonstrate the impact of natural products on modern pharmacotherapy. Analyses of approved drugs have shown that natural products and their derivatives constitute a substantial proportion of new molecular entities. Despite their importance, natural-product drug discovery has faced challenges including the complexity of extracts, limited availability of compounds, di?iculties in isolation and structural characterization, poor aqueous solubility, pharmacokinetic limitations, and di?iculties in identifying molecular targets. Recent advances in metabolomics, high- resolution mass spectrometry, genome mining, molecular networking, arti?cial intelligence, computational chemistry, microbial culturing, and biosynthetic ngineering are helping overcome many of these limitations. This review summarizes the sources, historical signi?cance, mechanisms of discovery, major therapeutic applications, advantages, challenges, and emerging technologies associated with natural-product-based drug discovery.

Keywords

natural products, drug discovery, medicinal chemistry

Introduction

× Popup Image

Drug discovery is a complex and time-consuming process involving the identification of biologically active molecules, optimization of their pharmacological properties, safety evaluation, and clinical development.

Natural products have historically served as one of the most productive sources of new therapeutic agents because living organisms produce structurally diverse molecules to survive, communicate, defend themselves, and interact with their environment. Natural products include alkaloids, flavonoids, terpenoids, glycosides, steroids, polyphenols, peptides, polyketides, and other secondary metabolites. Their structural complexity can provide interactions with biological targets that are diƯicult to reproduce using conventional syntheticchemistry. Several important medicines originated from natural sources. For example,morphine was isolated from opium poppy, quinine from Cinchona species,artemisinin from Artemisia annua, and paclitaxel from Taxus species.Microorganisms have also provided major drugs such as penicillin and other

antibiotics.

3.Major Sources of Natural Products

3.1 Plants

Plants are among the oldest and most extensively investigated sources ofmedicinal compounds. They produce numerous secondary metaboliteswith antimicrobial, anti-inflammatory, antioxidant, anticancer, antidiabetic,and cardiovascular activities.

figure

Examples include:

Atropa belladonna → atropine

Digitalis species → digoxin

Cinchona species → quinine

Catharanthus roseus → vincristine and vinblastine

Taxus species → paclitaxel

Artemisia annua → artemisinin

3..2 Microorganisms

Bacteria and fungi are highly important sources of natural products.

Microbial metabolites have contributed extensively to antibiotic andimmunosuppressive drug discovery.

Examples include:

Penicillin from Penicillium species

Streptomycin from Streptomyces griseus

Erythromycin from Saccharopolyspora erythraea

Cyclosporine from Tolypocladium inflatum

3.3 Marine Organisms

Marine organisms such as sponges, tunicates, algae, corals, and marine

microorganisms produce chemically unusual compounds because of theirunique environmental conditions.Marine natural products have contributed to the development of anticancerand antiviral agents and continue to be an important area of drug-discoveryresearch.

3.4 Animals

Some biologically active compounds are obtained from animals and otherorganisms. Venoms, toxins, peptides, and proteins have been investigatedas potential sources of therapeutics.For example, peptide-based drugs have been developed from molecules

originally identified in animal venoms.

4.Role of Natural Products in Drug Discovery

Natural products can contribute to drug discovery in several ways:irect drug development – the natural compound itself becomes a drug.Structural modification – the natural compound is chemically modified toimprove potency, selectivity, stability, or pharmacokinetics.

Lead compounds – natural products provide structures that serve as startingpoints for synthetic drug development.

Pharmacological tools – natural compounds can help identify biologicalpathways and therapeutic targets.

Traditional medicine-based discovery – ethnomedicinal knowledge canguide the selection of plants or organisms for investigation.

5.Modern Technologies in Natural-Product Drug Discovery

Modern science has transformed natural-product research.

5.1 Genomics

Genomic information can help researchers identify genes responsible forthe production of bioactive molecules.

5.2 Metabolomics

SOURCES OF NATURAL

PRODUCTS

PLANTS

MICROORGANISMS

MARINE

ORGANISMS

ANIMALS

Metabolomics enables researchers to analyze large numbers of metabolitesand identify chemical diƯerences between samples.

5.3 Molecular Docking

Computer-based molecular docking can predict how natural compoundsmay interact with proteins or other biological targets.

5.4 Artificial Intelligence

AI and machine-learning approaches can assist with:

Compound identification

Activity prediction

Target prediction

Structure optimization

Drug repurposing

Toxicity prediction

5.5 Synthetic Biology

Synthetic biology can potentially enable microorganisms to producevaluable natural compounds in controlled laboratory systems, reducingdependence on natural harvesting.

6. Natural Products in Cancer Drug Discovery

Cancer is one of the most important areas in which natural products have

contributed to drug development.

Examples include:

Paclitaxel

Vincristine

Vinblastine

Camptothecin derivatives

These compounds act through diƯerent mechanisms, including interferencewith cell division and DNA-related processes.atural products continue to be investigated for new anticancer molecules

and molecular targets.

7. Natural Products in Infectious Disease

Natural products have historically played a major role in infectious diseasetreatment.Penicillin and streptomycin demonstrated the importance ofmicroorganisms as sources of antibacterial agents.Natural-product research also contributed to antimalarial therapy through

quinine and artemisinin.The continuing problem of antimicrobial resistance has increased interest inidentifying new antimicrobial compounds and new mechanisms of action.

8. Natural Products and Drug Development

A natural compound does not automatically become a medicine. Drugdevelopment requires extensive evaluation.The development process generally includes:

Discovery → Lead identification → Lead optimization → Preclinical testing →

Clinical trials → Regulatory evaluation → Manufacturing → Post-marketing

monitoring

Natural molecules may be:Used directly as drugs

Chemically modified

Used as templates for synthetic drugs

Combined with other approaches to improve eƯicacy or safety

figure

9. Quality Control and Standardization

Quality control is essential for natural medicines.

Important parameters include:

Correct identification of the source

Purity

Active-marker concentration

Contamination testing

Microbial testing

Heavy-metal testing

Pesticide-residue testing

Appropriate storage

Standardized extraction and manufacturing procedures improve

consistency and safety.

10. Future Perspectives

The future of natural-product drug discovery is likely to involve theintegration of several disciplines.

Traditional knowledge + Natural-product chemistry + Molecular biology +

Genomics + Metabolomics + AI + Synthetic biology

This integrated approach may help overcome several traditional limitations.

Emerging areas include:

Biodiversity-based drug discovery

Microbiome-derived natural products

Marine natural products

Genome mining

AI-assisted screening

Sustainable production

Precision medicine

Natural-product-inspired synthetic compounds

CONCLUSION

Natural products remain one of the most valuable sources of newtherapeutic agents. Plants, microorganisms, marine organisms, and animalshave provided numerous compounds that have become importantmedicines or served as templates for drug development.Although natural-product research faces challenges such as complexchemistry, low abundance, toxicity, standardization, reproducibility, andsustainability, modern technologies are creating new opportunities.Genomics, metabolomics, advanced analytical chemistry, computationaldrug discovery, AI, and synthetic biology can make natural-productdiscovery faster and more systematic.Therefore, natural products should not be viewed only as traditionalremedies but as scientifically valuable sources of chemical diversity andnovel drug leads. Continued collaboration between pharmacology,chemistry, biotechnology, medicine, and computational science can help

convert natural-product discoveries into safe, eƯective, and clinically usefulmedicines.

REFERENCES

  1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83 (3):770-803.
  2. Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20 (3):200-216.
  3. Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14 (2):111-129.
  4. Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract. 2016;25 (Suppl 2):41-59.
  5. Patwardhan B, Mashelkar R. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009;14 (15-16):804-811.
  6. Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012;2 (2):303-336.
  7. Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. AAPS J. 2006;8 (2):E239-E253.
  8. Bernardini S, Tiezzi A, Laghezza Masci V, Ovidi E. Natural products for human health: an historical overview of the drug discovery approaches. Nat Prod Res. 2018;32 (16):1926-1950.

Reference

  1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83 (3):770-803.
  2. Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20 (3):200-216.
  3. Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14 (2):111-129.
  4. Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract. 2016;25 (Suppl 2):41-59.
  5. Patwardhan B, Mashelkar R. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009;14 (15-16):804-811.
  6. Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012;2 (2):303-336.
  7. Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. AAPS J. 2006;8 (2):E239-E253.
  8. Bernardini S, Tiezzi A, Laghezza Masci V, Ovidi E. Natural products for human health: an historical overview of the drug discovery approaches. Nat Prod Res. 2018;32 (16):1926-1950.

Photo
Shaik. Muneer
Corresponding author

SIMS College Of Pharmacy, Mangaldas Nagar, Guntur,Andhra Pradesh,India 522001.

Photo
Pasupuleti. Gayathri
Co-author

SIMS College Of Pharmacy, Mangaldas Nagar, Guntur,Andhra Pradesh,India 522001.

Shaik. Muneer, Pasupuleti. Gayathri, Products in Natural Drug Discovery, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 10, 4497-4501. https://doi.org/10.5281/zenodo.23727538

More related articles
Comparative Cardiovascular and Heart-Failure Outco...
Kalisetty Venkata Sai Sachethan, Harshini Shyamapanth, Summayya S...
Prosthodontic Determinants of Peri-Implant Tissue ...
Priya, Deepesh Hingorani, Jitendra Khetan...
Immunoinformatics Based Design and in Silico Prediction of a Multi-Epitope Cockt...
Anita Chauhan, Luvina Dogra, Aarti Lagwal, Tanvi Sharma...
Animal Venoms as a Source of Therapeutics: Insights into Anticancer, Cardiovascu...
Soniya Acharya, Dr. G. C. Mamatha, Sindhu S., Sahana R. G., Ankitha A. H., Sahidul Islam...
Formulation and Evaluation of a Phytotherapeutic Antimicrobial Cream Utilizing C...
Manjunath Halkeri, Aneel, Ajeya Kumar, V. Bharathkumar, Raddi Krishnaraj, Naveen Kumar...
Related Articles
Regulatory Reliance and Recognition in Pharmaceutical Product Registration: A Cr...

A PHP Error was encountered

Severity: 8192

Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated

Filename: frontend/article.php

Line Number: 890

...
Integrated in Silico Profiling of Moringa oleifera Leaf Constituents as Collagen...
Frank Deshmukh, Mahima Turkar, Ankita Mishra, Dr. Rohit Sahu...
Type of Manuscript: Review Article...
P. Lazaru, P. Sandhya Rani, M. Mary Rani, Sk. Khasimunnysa, Ch. Soniya, Ch. Pooja, J. N. Suresh Kuma...
Comparative Cardiovascular and Heart-Failure Outcomes of Modern Glucose-Lowering...
Kalisetty Venkata Sai Sachethan, Harshini Shyamapanth, Summayya Sanober, Montu Somaram Kumhar...
More related articles
Comparative Cardiovascular and Heart-Failure Outcomes of Modern Glucose-Lowering...
Kalisetty Venkata Sai Sachethan, Harshini Shyamapanth, Summayya Sanober, Montu Somaram Kumhar...